10th Panhellenic Conference of the Hellenic Society of Headache, Athens 15-17 March 2018
November 2, 2023Pharmazac launched the new product Etrozac / etoricoxib.
November 2, 2023Pharmazac launched the new product Quental/quetiapine

Pharmazac launched the new product Quental/quetiapine 50,200,300 and 400mg in prolonged release tablets for the treatment of schizophrenia and bipolar disorders.
Related News
November 2, 2023
We are becoming a manufacturer and key player in radiopharmaceuticals
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
November 2, 2023
We are welcoming KRKA in Greece
We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac iw happy to announce that it will begin in December ΄20 […]
November 2, 2023
Pharmazac launched the new product Cinacalcet
Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney […]
November 2, 2023
PharmaZac sponsors the medical book “Epilepsy and Movement Disorders”
PharmaZac sponsors the medical book “Epilepsy and Movement Disorders” of Dr. A. Alexoudi Neurologist Ph.D of National and Kapodistrian University of Athens and Dr. S. Gatzonis, […]
